Literature DB >> 3451944

Blood thiamine levels in outpatients with diabetes mellitus.

N Saito1, M Kimura, A Kuchiba, Y Itokawa.   

Abstract

In 46 diabetic outpatients consisting of 20 males and 26 females not given thiamine treatment, the blood thiamine level was 46.9 +/- 28.5 ng/ml (mean +/- SD) and only 23.9% of all cases had a value of more than the normal lower limit (50 ng/ml). Erythrocyte transketolase activity was 443.8 +/- 107.7 micrograms/ml/h and only 20.9% had a value of ore than the normal lower limit (50 micrograms/ml/h), and the erythrocyte TPP effect was 16.6 +/- 13.2%. Moreover, there was a significant positive correlation (r = 0.97) between the blood thiamine level and erythrocyte transketolase activity, and a significant inverse correlation (r = -0.525, r = -0.576) between blood thiamine level and/or erythrocyte transketolase activity and the erythrocyte TPP effect. In 24 diabetic outpatients consisting of 14 males and 10 females given thiamine treatment, the blood thiamine level was 96.5 +/- 44.5 ng/ml/h excluding one case (621.7 ng/ml), and it was higher than the normal lower limit in 83% of all cases. Erythrocyte transketolase activity was 513.9 +/- 133.4 micrograms/ml/h and it was higher than the normal lower limit in 58.3%. Erythrocyte TPP effect was 5.84 +/- 8.39%. There was also a significant positive correlation (r = 0.663) between blood thiamine level and erythrocyte transketolase activity, and a significant inverse correlation (r = 0.0668, r = 0.834) between blood thiamine level and/or erythrocyte transketolase activity and erythrocyte TPP effect. Blood thiamine level and erythrocyte transketolase activity were significantly higher in diabetic outpatients given thiamine treatment than in diabetic outpatients not given thiamine treatment, while the erythrocyte TPP effect was significantly lower in diabetic outpatients given thiamine treatment than in diabetic outpatients not given thiamine treatment. There was no direct relationship between the lowered response of patellar tendon reflex and the biochemical status of thiamine. From the above findings it was concluded that diabetic outpatients tend to have a low blood thiamine level, with low erythrocyte transketolase activity and high erythrocyte TPP effect, and showed marginal thiamine deficiency.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3451944     DOI: 10.3177/jnsv.33.421

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  24 in total

1.  Tspan-1 interacts with the thiamine transporter-1 in human intestinal epithelial cells and modulates its stability.

Authors:  Svetlana M Nabokina; Sundar Rajan Senthilkumar; Hamid M Said
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-11       Impact factor: 4.052

2.  The relationship between lactate and thiamine levels in patients with diabetic ketoacidosis.

Authors:  Ari Moskowitz; Amanda Graver; Tyler Giberson; Katherine Berg; Xiaowen Liu; Amy Uber; Shiva Gautam; Michael W Donnino
Journal:  J Crit Care       Date:  2013-08-28       Impact factor: 3.425

3.  Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis.

Authors:  S Gadau; C Emanueli; S Van Linthout; G Graiani; M Todaro; M Meloni; I Campesi; G Invernici; F Spillmann; K Ward; P Madeddu
Journal:  Diabetologia       Date:  2006-01-17       Impact factor: 10.122

Review 4.  Intestinal absorption of water-soluble vitamins in health and disease.

Authors:  Hamid M Said
Journal:  Biochem J       Date:  2011-08-01       Impact factor: 3.857

5.  Biochemical changes correlated with blood thiamine and its phosphate esters levels in patients with diabetes type 1 (DMT1).

Authors:  Nasser M Al-Daghri; Mohammed Alharbi; Kaiser Wani; Sherif H Abd-Alrahman; Eman Sheshah; Majed S Alokail
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

6.  Posttranscriptional regulation of thiamin transporter-1 expression by microRNA-200a-3p in pancreatic acinar cells.

Authors:  Kalidas Ramamoorthy; Kasin Yadunandam Anandam; Tomoya Yasujima; Padmanabhan Srinivasan; Hamid M Said
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-07-20       Impact factor: 4.052

7.  High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats.

Authors:  R Babaei-Jadidi; N Karachalias; C Kupich; N Ahmed; P J Thornalley
Journal:  Diabetologia       Date:  2004-12-11       Impact factor: 10.122

8.  Association of TM4SF4 with the human thiamine transporter-2 in intestinal epithelial cells.

Authors:  Veedamali S Subramanian; Svetlana M Nabokina; Hamid M Said
Journal:  Dig Dis Sci       Date:  2013-11-27       Impact factor: 3.199

9.  Effects of sulbutiamine on diabetic polyneuropathy: an open randomised controlled study in type 2 diabetics.

Authors:  K K Kiew; W B Wan Mohamad; A Ridzuan; M Mafauzy
Journal:  Malays J Med Sci       Date:  2002-01

10.  Inhibition of Intestinal Thiamin Transport in Rat Model of Sepsis.

Authors:  Catherine S Sassoon; Ercheng Zhu; Liwei Fang; Veedamali S Subramanian; Hamid M Said
Journal:  Crit Care Med       Date:  2016-09       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.